Welcome to the Bay Area Virus Network, a resource for scientists, engineers, and clinical researchers in the San Francisco Bay Area.

To join the network, add yourself to the bayviro listserv.

If you run a laboratory or research program in the bay area, please add yourself to our listing.



The 4th Annual Bay Area Symposium on Viruses will be held on Friday, May 30, 2014! 

The 4th Annual Bay Area Symposium on Viruses returns to the University of California Berkeley. The symposium promises to carry on the tradition of the last three years with an engaging line-up of plenary speakers and excellent networking opportunities. This year's symposium made possible with the generous support of thethe Henry Wheeler Center for Emerging and Neglected Diseases (CEND), Gilead, Alios BioPharma, Blood Systems Research Institute, Center for AIDS Research, and Novartis. 


8:00 am


9:00 am

Introduction and Welcome Remarks

9:15 am

Jody Baron (UCSF)

A mouse model of human hepatitis B:  A tool to identify and test therapeutic targets  

9:45 am

 Bryce Falk (UC Davis)

Criniviruses have the most complex genomes and virions of +sense ssRNA plant viruses

10:15 am

Xing Cheng (MedImmune)

Developing novel Newcastle disease virus as oncolytic virus for virotherapy

10:30 am

Coffee Break

11:00 am

Introduction Roundtable

11:10 am

Peter S. Kim (Stanford)

The gp41 Pre-Hairpin intermediate as a vaccine target

11:40 am

Philip Norris (BSRI)

Immune determinates of WNV infection outcome

12:10 pm

Zoe Davis (UC Berkeley)

Global mapping of herpesvirus-host protein complexes reveals a novel transcription strategy for late genes

12:30 pm

Lunch/Industry Roundtable

2:00 pm

Romas Geleziunas (Gilead)

Concepts of combination therapy for HIV eradication 

2:30 pm

Ann Arvin (Stanford)

Molecular mechanisms of varicella-zoster virus pathogenesis

3:00 pm

Ashley Acevedo (UCSF)

APOBEC3H: A novel riboviral effector

3:15 pm

Coffee Break

3:45 pm

Laurent Coscoy (UC Berkeley)

A role for activation-induced cytidine deaminase in innate immune defense against KSHV.

4:15 pm

Elizabeth Tanner (Stanford)

Suppressing antiviral resistance via dominant drug targets

4:30 pm

Poster Session/Cocktail Hour